Matches in Wikidata for { <http://www.wikidata.org/entity/Q89480261> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q89480261 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q89480261 description "scientific article published on 01 July 2018" @default.
- Q89480261 description "wetenschappelijk artikel" @default.
- Q89480261 description "наукова стаття, опублікована в липні 2018" @default.
- Q89480261 name "Hyperlipidemia: Management with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors" @default.
- Q89480261 name "Hyperlipidemia: Management with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors" @default.
- Q89480261 type Item @default.
- Q89480261 label "Hyperlipidemia: Management with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors" @default.
- Q89480261 label "Hyperlipidemia: Management with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors" @default.
- Q89480261 prefLabel "Hyperlipidemia: Management with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors" @default.
- Q89480261 prefLabel "Hyperlipidemia: Management with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors" @default.
- Q89480261 P1433 Q89480261-B35B0A57-237A-4A43-919A-4737D83B2352 @default.
- Q89480261 P1476 Q89480261-3C936589-2D59-406D-BA8C-CDD73DA74612 @default.
- Q89480261 P2093 Q89480261-20D1B939-9E63-48EF-8346-26817168EA87 @default.
- Q89480261 P2093 Q89480261-5FE53F76-B029-4CDA-8D74-D9DB3BDC29C7 @default.
- Q89480261 P2093 Q89480261-8E642980-88B0-46A4-B70D-4438EAD50667 @default.
- Q89480261 P2093 Q89480261-B435915C-216A-485B-9AA2-25B9DE891695 @default.
- Q89480261 P2093 Q89480261-B52A131F-2643-45B4-9DB5-4F9585CCC097 @default.
- Q89480261 P2093 Q89480261-F1087A12-111D-494E-9AB0-4F850C93E29C @default.
- Q89480261 P304 Q89480261-ED1D3192-3C5E-4515-AAEC-9019EF03DB60 @default.
- Q89480261 P31 Q89480261-DD5D4627-E47E-4A79-BA56-0351A81CE023 @default.
- Q89480261 P356 Q89480261-830CC88D-FCE7-43D0-8A3C-219A41B20EB6 @default.
- Q89480261 P433 Q89480261-ABC0179D-944C-4775-B12D-B38B9BB4360C @default.
- Q89480261 P478 Q89480261-F6ECB115-F276-4F72-A45A-C66616B48B20 @default.
- Q89480261 P577 Q89480261-84D05EFD-27FE-4941-9EA3-8306E3908106 @default.
- Q89480261 P698 Q89480261-8BB93BA3-642D-47FA-A7AA-23C59929009B @default.
- Q89480261 P356 JABFM.2018.04.170447 @default.
- Q89480261 P698 29986989 @default.
- Q89480261 P1433 Q6296088 @default.
- Q89480261 P1476 "Hyperlipidemia: Management with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors" @default.
- Q89480261 P2093 "Lekha K George" @default.
- Q89480261 P2093 "Mannu Nayyar" @default.
- Q89480261 P2093 "Muhammed Shahreyar" @default.
- Q89480261 P2093 "Nadish Garg" @default.
- Q89480261 P2093 "Salem A Salem" @default.
- Q89480261 P2093 "Santhosh K G Koshy" @default.
- Q89480261 P304 "628-634" @default.
- Q89480261 P31 Q13442814 @default.
- Q89480261 P356 "10.3122/JABFM.2018.04.170447" @default.
- Q89480261 P433 "4" @default.
- Q89480261 P478 "31" @default.
- Q89480261 P577 "2018-07-01T00:00:00Z" @default.
- Q89480261 P698 "29986989" @default.